Safety and tolerability of cariprazine in patients with acute exacerbation of schizophrenia: a pooled analysis of four phase II/III randomized, double-blind, placebo-controlled studies.

MLA

Earley, Willie, et al. “Safety and Tolerability of Cariprazine in Patients with Acute Exacerbation of Schizophrenia: A Pooled Analysis of Four Phase II/III Randomized, Double-Blind, Placebo-Controlled Studies.” International Clinical Psychopharmacology, vol. 32, no. 6, Nov. 2017, pp. 319–28. EBSCOhost, https://doi.org/10.1097/YIC.0000000000000187.

APA

Earley, W., Durgam, S., Lu, K., Laszlovszky, I., Debelle, M., & Kane, J. M. (2017). Safety and tolerability of cariprazine in patients with acute exacerbation of schizophrenia: a pooled analysis of four phase II/III randomized, double-blind, placebo-controlled studies. International Clinical Psychopharmacology, 32(6), 319–328. https://doi.org/10.1097/YIC.0000000000000187

Chicago

Earley, Willie, Suresh Durgam, Kaifeng Lu, István Laszlovszky, Marc Debelle, and John M Kane. 2017. “Safety and Tolerability of Cariprazine in Patients with Acute Exacerbation of Schizophrenia: A Pooled Analysis of Four Phase II/III Randomized, Double-Blind, Placebo-Controlled Studies.” International Clinical Psychopharmacology 32 (6): 319–28. doi:10.1097/YIC.0000000000000187.